MX2011010358A - Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana. - Google Patents

Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana.

Info

Publication number
MX2011010358A
MX2011010358A MX2011010358A MX2011010358A MX2011010358A MX 2011010358 A MX2011010358 A MX 2011010358A MX 2011010358 A MX2011010358 A MX 2011010358A MX 2011010358 A MX2011010358 A MX 2011010358A MX 2011010358 A MX2011010358 A MX 2011010358A
Authority
MX
Mexico
Prior art keywords
quinolin
hydroxyethyl
derivatives
antibacterial activity
azaisosteric
Prior art date
Application number
MX2011010358A
Other languages
English (en)
Inventor
Christian Hubschwerlen
Georg Rueedi
Jean-Philippe Surivet
Cornelia Zumbrunn Acklin
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MX2011010358A publication Critical patent/MX2011010358A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención se relaciona con compuestos antibacterianos de la fórmula I en la cual R1 representa alcoxi; cada uno de U y V representa CH y W representa CH o N, o U representa N, y V representa CH y W representa N, o cada uno de U y V representa N y W representa CH; R2 representa hidrógeno o flúor cuando W representa CH o R2 representa hidrógeno cuando W representa N; A representa O o CH2 Y representa CH o N; Q representa O o S; y n representa 0 ó 1; y sales de tales compuestos.
MX2011010358A 2009-04-09 2010-04-08 Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana. MX2011010358A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2009051510 2009-04-09
PCT/IB2010/051517 WO2010116337A1 (en) 2009-04-09 2010-04-08 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity

Publications (1)

Publication Number Publication Date
MX2011010358A true MX2011010358A (es) 2011-11-01

Family

ID=42199672

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011010358A MX2011010358A (es) 2009-04-09 2010-04-08 Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana.

Country Status (15)

Country Link
US (1) US8415375B2 (es)
EP (1) EP2417141B1 (es)
JP (1) JP5639639B2 (es)
KR (1) KR101729345B1 (es)
CN (1) CN102361875B (es)
AR (1) AR076222A1 (es)
AU (1) AU2010233387B2 (es)
BR (1) BRPI1015310A8 (es)
CA (1) CA2756727C (es)
ES (1) ES2438742T3 (es)
MX (1) MX2011010358A (es)
PL (1) PL2417141T3 (es)
RU (1) RU2540862C2 (es)
TW (1) TWI455937B (es)
WO (1) WO2010116337A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
AU2012275499A1 (en) * 2011-06-27 2013-12-19 Kyorin Pharmaceutical Co., Ltd. Bridged bicyclic compounds for the treatment of bacterial infections
AR087875A1 (es) 2011-09-16 2014-04-23 Actelion Pharmaceuticals Ltd Proceso para la elaboracion de derivados de piridazina como intermediarios de sintesis de antibioticos
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1095611A1 (ru) * 1982-09-10 2007-06-27 Краснодарский ордена Трудового Красного Знамени политехнический институт Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
EP0934932A4 (en) * 1996-08-22 2002-06-26 Meiji Seika Kaisha CHINOLINE DERIVATIVES AND PSYCHOTROPES MEDIUM
GB0112834D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AR040335A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
WO2006002047A2 (en) 2004-06-15 2006-01-05 Glaxo Group Limited Antibacterial agents
CA2580621A1 (en) * 2004-09-24 2006-03-30 Actelion Pharmaceuticals Ltd New bicyclic antibiotics
DE602006008932D1 (de) * 2005-05-25 2009-10-15 Actelion Pharmaceuticals Ltd Neue antibiotische derivate
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2006137485A1 (ja) 2005-06-24 2006-12-28 Toyama Chemical Co., Ltd. 新規な含窒素複素環化合物およびその塩
CN101341126A (zh) * 2005-10-13 2009-01-07 莫弗凯姆联合化学股份公司 具有抗菌活性的5-喹啉衍生物
CN101454319B (zh) 2006-05-26 2012-06-27 富山化学工业株式会社 新杂环化合物或其盐及其中间体
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
WO2008071962A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Pteridines and pyrimidinopyridines as antibacterial agents
WO2008071964A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Naphthyridine bactericides
WO2008071981A1 (en) 2006-12-15 2008-06-19 Astrazeneca Ab Piperidines for the treatment of bacterial infections
TW200831517A (en) 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
US8389524B2 (en) 2007-04-20 2013-03-05 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
EP2005995A1 (en) 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
WO2009001126A1 (en) 2007-06-27 2008-12-31 Astrazeneca Ab Substituted piperidine derivatives and their use as antibaterial agents
GB0800367D0 (en) 2008-01-09 2008-02-20 Glaxo Group Ltd Compounds
AR070458A1 (es) 2008-02-22 2010-04-07 Actelion Pharmaceuticals Ltd Derivados de oxazolidina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de una infeccion bacteriana.
AU2009254738B2 (en) * 2008-06-03 2014-05-08 Idorsia Pharmaceuticals Ltd [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
TWI436999B (zh) 2008-10-10 2014-05-11 Actelion Pharmaceuticals Ltd 唑啶基抗生素
NZ593891A (en) 2008-12-12 2013-05-31 Actelion Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
AR076222A1 (es) 2011-05-26
WO2010116337A1 (en) 2010-10-14
JP5639639B2 (ja) 2014-12-10
PL2417141T3 (pl) 2014-03-31
AU2010233387A1 (en) 2011-11-24
EP2417141A1 (en) 2012-02-15
US20120040989A1 (en) 2012-02-16
ES2438742T3 (es) 2014-01-20
CA2756727A1 (en) 2010-10-14
KR101729345B1 (ko) 2017-04-21
AU2010233387B2 (en) 2015-01-15
RU2011145052A (ru) 2013-05-20
TWI455937B (zh) 2014-10-11
JP2012523407A (ja) 2012-10-04
CA2756727C (en) 2017-05-02
TW201040182A (en) 2010-11-16
US8415375B2 (en) 2013-04-09
RU2540862C2 (ru) 2015-02-10
CN102361875A (zh) 2012-02-22
BRPI1015310A8 (pt) 2017-12-26
CN102361875B (zh) 2014-08-20
EP2417141B1 (en) 2013-10-16
BRPI1015310A2 (pt) 2016-05-24
KR20120014240A (ko) 2012-02-16

Similar Documents

Publication Publication Date Title
MX2009010071A (es) Derivados de aril isoxazolina insecticidas.
ZA201002987B (en) Tropane compounds
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
EA201290397A1 (ru) 1,3,4-оксадиазол-2-карбоксамидное соединение
MX343596B (es) Sulfonamidas nematocidas.
TW200734314A (en) Piperazine compounds having herbicidal action
MY156669A (en) Pesticidal composition and its use
MX341133B (es) Compuestos y metodos para la inhibición de hdac.
MD20110063A2 (en) Herbicidal compositions containing benzoylpyrazole compounds
UA102310C2 (ru) Гетероциклические сульфонамиды, их применение и фармацевтические композиции
MX2016003196A (es) Derivados antibacterianos del 2h-indazol.
MA32956B1 (fr) Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane
MX339557B (es) Composicion plaguicida y su uso.
MX2011010358A (es) Derivados de 2-hidroxietil-1h-quinolin-2-ona y sus analogos azaisostericos con actividad antibacteriana.
EA201171289A1 (ru) Композиция для укладки волос
IN2012DN03343A (es)
MX2009007416A (es) Derivados de sulfonamida como inhibidores de quimasa.
GB201020397D0 (en) Compounds
TN2012000034A1 (en) Methylpyrrolopyrimidinecarboxamides
IN2012DN01251A (es)
EP2183256A4 (en) THERAPEUTIC COMPOUNDS
DE602008002598D1 (en) Cyclohexylderivate
MX2009002606A (es) Derivados de arginina con actividad antagonistica de np-1.
TW200801011A (en) New compounds II
CO6700877A2 (es) Derivado de difenil sulfuro y producto farmacéutico que contiene el mismo como ingrediente activo

Legal Events

Date Code Title Description
FG Grant or registration